MYELOFIBROSIS DUE TO AND FOLLOWING POLYCYTHEMIA VERA
Clinical trials for MYELOFIBROSIS DUE TO AND FOLLOWING POLYCYTHEMIA VERA explained in plain language.
Never miss a new study
Get alerted when new MYELOFIBROSIS DUE TO AND FOLLOWING POLYCYTHEMIA VERA trials appear
Sign up with your email to follow new studies for MYELOFIBROSIS DUE TO AND FOLLOWING POLYCYTHEMIA VERA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to free blood cancer patients from frequent transfusions
Disease control Recruiting nowThis study tests an experimental drug called DISC-0974 in about 150 adults with myelofibrosis or myelodysplastic syndrome who also have anemia. The goal is to see if the drug is safe and can help patients need fewer or no blood transfusions. The study is in early to mid stages an…
Matched conditions: MYELOFIBROSIS DUE TO AND FOLLOWING POLYCYTHEMIA VERA
Phase: PHASE1, PHASE2 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated May 26, 2026 11:46 UTC
-
New combo therapy aims to tame bone marrow cancer
Disease control Recruiting nowThis early-stage study tests whether adding abemaciclib to the standard drug ruxolitinib is safe and effective for people with myelofibrosis, a type of bone marrow cancer. About 18 adults who are already on a stable dose of ruxolitinib will take the combination. The main goal is …
Matched conditions: MYELOFIBROSIS DUE TO AND FOLLOWING POLYCYTHEMIA VERA
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New registry aims to unlock secrets of rare blood cancers
Knowledge-focused Recruiting nowThis study is a long-term registry for people with myeloproliferative neoplasms (MPNs), a group of rare blood cancers. Researchers will collect health records, surveys, and insurance data from 5,000 participants over at least five years to understand how the disease progresses an…
Matched conditions: MYELOFIBROSIS DUE TO AND FOLLOWING POLYCYTHEMIA VERA
Sponsor: MPN Research Foundation • Aim: Knowledge-focused
Last updated May 26, 2026 11:33 UTC